This work is licensed under the Creative Commons Attribution 4.0 International License.
Fuchs A, Gotta V, Decker M-L, Szinnai G, Baumann P, Bonhoeffer J., Ritzet N., Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial. Clin Microbiol Infect 2018; 24: 1341.e1–1341.e7 doi:10.1016/j.cmi.2018.03.016FuchsAGottaVDeckerM-LSzinnaiGBaumannPBonhoefferJ.RitzetN.Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial2018241341e1–1341.e710.1016/j.cmi.2018.03.01629555393Open DOISearch in Google Scholar
Ciuca IM, Pop L, Horhat F.G., Rogobete AF, Role of biomarkers in cystic fibrosis pulmonary disease, Pediatru.ro 2017; 46(2): 8–10 doi: 10.26416/Pedi.46.2.2017.806CiucaIMPopLHorhatF.G.RogobeteAFRole of biomarkers in cystic fibrosis pulmonary disease201746281010.26416/Pedi.46.2.2017.806Open DOISearch in Google Scholar
Wallace, R. G., Twomey, L. C., Custaud, M. A., Moyna, N., Cummins, P. M., Mangone, M., & Murphy, R. P. (2016). Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment. BioMed Research International, 2016, [2465763]. https://doi.org/10.1155/2016/2465763WallaceR. G.TwomeyL. C.CustaudM. A.MoynaN.CumminsP. M.MangoneM.&MurphyR. P.2016Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment.20162465763https://doi.org/10.1155/2016/246576310.1155/2016/2465763474976826942189Search in Google Scholar
Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4(4):406–417. doi:10.1513/pats.200703-044BRSagelSDChmielJFKonstanMWSputum biomarkers of inflammation in cystic fibrosis lung disease.20074440641710.1513/pats.200703-044BR264760517652508Open DOISearch in Google Scholar
Bedreag OH, Sandesc D, Chiriac SD, Rogobete AF, Cradigati AC, Sarandan M, Papurica M et al. The Use of Circulating miR-NAs as Biomarkers for Oxidative Stress in Critically Ill Poly-trauma Patients. Clinical Laboratory. 2016; 62(3):263–274. DOI: 10.7754/clin.lab.2015.150740.BedreagOHSandescDChiriacSDRogobeteAFCradigatiACSarandanMPapuricaMet al.The Use of Circulating miR-NAs as Biomarkers for Oxidative Stress in Critically Ill Poly-trauma Patients.201662326327410.7754/clin.lab.2015.150740.Open DOISearch in Google Scholar
Dumache R, Rogobete AF, Bedreag OH, Sarandan M, Cradigati AC , Papurica M, Corina Dumbuleu M, et al. Use of miR-NAs as biomarkers in sepsis. Anal Cell Pathol (Amst) 2015; 2015:186716. doi:10.1155/2015/186716DumacheRRogobeteAFBedreagOHSarandanMCradigatiACPapuricaMCorinaDumbuleu Met al.Use of miR-NAs as biomarkers in sepsis2015201518671610.1155/2015/186716449937526221578Open DOISearch in Google Scholar
Quon BS, Ngan DA, Wilcox PG, Man SFP, Sin DD (2014) Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis. PLOS ONE 9(2): e89341. https://doi.org/10.1371/journal.pone.0089341QuonBSNganDAWilcoxPGManSFPSinDD2014Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis.92e89341https://doi.org/10.1371/journal.pone.008934110.1371/journal.pone.0089341393071824586701Search in Google Scholar
Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA; Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med 2017; 195(12):1567–1575. doi:10.1164/rccm.201606-1107CIRanganathanSCHallGLSlyPDStickSMDouglasTAEarly Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It?2017195121567157510.1164/rccm.201606-1107CI685072527911585Open DOISearch in Google Scholar
Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res 2010; 11(1): 177. doi:10.1186/1465-9921-11-177 2010, 11:177DecraeneAWillems-WidyastutiAKasranADeBoeck KBullensDMDupontLJElevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients201011117710.1186/1465-9921-11-1772010, 11177Open DOISearch in Google Scholar
Rao JR, Nelson D, Moore JE, Millar BC, Goldsmith CE, Rendall J, Elborn JS. Non-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis. Br J Biomed Sci 2010; 67(3): 126–132 . doi:10.1 080/09674845.2010.11730309.RaoJRNelsonDMooreJEMillarBCGoldsmithCERendallJElbornJSNon-coding small (micro) RNAs of Pseudomonas aeruginosa isolated from clinical isolates from adult patients with cystic fibrosis201067312613210.1080/09674845.2010.11730309.20973407Open DOISearch in Google Scholar
Tsuchiya M, Kumar P, Bhattacharyya S, Chattoraj S, Srivastava M, Pollard HB, Biswas R. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells. J Interferon Cytokine Res 2013; 33(3): 121–129. doi:10.1089/ jir.2012.0074TsuchiyaMKumarPBhattacharyyaSChattorajSSrivastavaMPollardHBBiswasRDifferential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells201333312112910.1089/jir.2012.0074Open DOISearch in Google Scholar
Bedreag, O. , Rogobete, A. , Dumache, R. , Sarandan, M. , Cradigati, A. , Papurica, M. , Craciunescu, M. , Sandesc, D. et al. (2015). Use of circulating microRNAs as biomarkers in critically ill polytrauma patients. Biomarkers and Genomic Medicine 2016, 7(4): 131–138 doi: 10.1016/j.bgm.2015.11.002BedreagO.RogobeteA.DumacheR.SarandanM.CradigatiA.PapuricaM. CraciunescuM.SandescD.et al.2015Use of circulating microRNAs as biomarkers in critically ill polytrauma patients.20167413113810.1016/j.bgm.2015.11.002Open DOISearch in Google Scholar
Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003; 2(1): 29–34. doi:10.1016/S1569-1993(02)00141-8LeeTWBrownleeKGConwaySPDentonMLittlewoodJMEvaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.200321293410.1016/S1569-1993(02)00141-8Open DOISearch in Google Scholar
Mauch RM, Rossi CL, Ribeiro JD, Ribeiro AF, Nolasco da Silva MT, Levy CE. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA). Diagn Pathol 2014; 9:158. doi:10.1186/s13000-014-0158-zMauchRMRossiCLRibeiroJDRibeiroAFNolascoda Silva MTLevyCEAssessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA)2014915810.1186/s13000-014-0158-z418279025146522Open DOISearch in Google Scholar
da Silva Filho LV, Tateno AF, Martins KM, et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 2007; 42(10): 938–944. doi:10.1002/ppul.20686daSilva Filho LVTatenoAFMartinsKMet al.The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis2007421093894410.1002/ppul.2068617722007Open DOISearch in Google Scholar
Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000;162(6):2172–2176. doi:10.1164/ajrccm.162.6.2003106GrasemannHKnauerNBüscherRHübnerKDrazenJMRatjenFAirway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene200016262172217610.1164/ajrccm.162.6.200310611112133Open DOISearch in Google Scholar
Smith D, Spaněl P, Gilchrist FJ, Lenney W. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res 2013;7(4):044001. doi:10.1088/1752– 7155/7/4/044001SmithDSpanělPGilchristFJLenneyWHydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection20137404400110.1088/1752–7155/7/4/044001Open DOISearch in Google Scholar
Enderby B, Smith D, Carroll W, Lenney W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol 2009; 44(2): 142– 147. doi:10.1002/ppul.20963EnderbyBSmithDCarrollWLenneyWHydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.2009442142–14710.1002/ppul.2096319148935Open DOISearch in Google Scholar
Gilchrist F., Belcher J., Jones A.M., Smith D., Smyth A.R., Southern K.W., Španěl P., Webb A.K., Lenney W. Exhaled breath hydrogen cyanide as a marker of earlyGilchristF.BelcherJ.JonesA.M. SmithD.SmythA.R.SouthernK.W. ŠpanělP.WebbA.K.LenneyW.Search in Google Scholar
Pseudomonas aeruginosa infection in children with cystic fibrosis, ERJ Open ResearchSearch in Google Scholar
Zhou, X., Li, X., Ye, Y. et al. MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits. Nat CommunZhouX.LiX.YeYet al.MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuitsSearch in Google Scholar
5, 3619 (2014). https://doi.org/10.1038/ncomms46192014https://doi.org/10.1038/ncomms461910.1038/ncomms4619401155924717937Search in Google Scholar
Dai, L. L., Gao, J. X., Zou, C. G., Ma, Y. C., Zhang, K. Q. Mir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection. PLoS Pathog 2015 11:e1004606. doi: 10.1371/journal.ppat.1004606DaiL. L.GaoJ. X.ZouC. G.MaY. C.ZhangK. QMir-233 modulates the unfolded protein response in C. elegans during Pseudomonas aeruginosa infection201511e100460610.1371/journal.ppat.1004606428761425569229Open DOISearch in Google Scholar